CIK: 2032345 - Address: 4960 Peachtree Industrial Blvd, Suite 240, Norcross, GA 30071
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/6/26 16:53
1/2/26
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramGAOChief MeM.d00.000600D
1/6/26 16:53
1/2/26
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramGAOChief MeS.dm-2323.870-60-1000D
1/5/26 16:07
12/31/25
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramGAOChief MeM.d101.23080D
1/5/26 16:07
12/31/25
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramGAOChief MeS.d-334.070-8-1000D
12/19/25 16:06
12/17/25
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramGAOChief MeS.d-1377.040-19-1000D
12/19/25 16:06
12/17/25
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramGAOChief MeM.d352.370150D
11/14/25 16:02
11/13/25
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramGAOChief MeS.d-6635.470-121-964D
11/14/25 16:02
11/13/25
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramGAOChief MeM.d2152.170994D
12/26/24 08:20
12/23/24
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramPAOChief MeM.d00.0004026D
12/26/24 08:20
12/23/24
GALTGalectin Therapeutics IncNVHealthDrugPharmaceutical PreparationsJamil KhurramPAOChief MeS.d-120.88210-14-3426D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact